Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

B -- Contract Research Organization for Immunogenicity Studies

Active
RFQ-BARDA-08-19Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The United States Government is seeking to contract a Contract Research Organization to perform pre-clinical animal immunogenicity studies involving vaccines containing H5N1 antigens and adjuvants produced under BARDA contracts. These studies are essential to support the filing of an Investigational New Drug (IND) application by NIH and BARDA, contributing to an interagency effort aimed at enhancing U.S. pandemic preparedness. The contract will be awarded through a commercial item acquisition process using Simplified Acquisition Procedures in accordance with FAR Parts 12 and 13, and multiple Indefinite Delivery/Indefinite Quantity contracts are expected to be awarded. A Request for Quotations is anticipated to be issued on March 21, 2008, with a response deadline set fifteen days later. The contracting action is identified under the solicitation number RFQ-BARDA-08-19 and falls under NAICS code 325414. The Contracting Officer responsible for this acquisition is Schuyler T Eldridge, who can be contacted via email or phone. The effort represents a key step in advancing clinical evaluation of these vaccines to support pandemic response capabilities.

General Info

US government seeks CRO for pre-clinical H5N1 vaccine studies supporting IND application.

Agency

N/A

Contract Value

$5,000

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Awardee

MRIGLOBAL

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhasePresolicitation
Posted

Presolicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Schuyler T EldridgeContracting Officer

Full Description

Show more
The purpose of this notice is to synopsize a proposed contract action. This is a pre-solicitation notice and does not commit the Government to issue a solicitation or to award a contract. The United States Government (USG) has a need to acquire the services of a Contract Research Organization to conduct pre-clinical animal immunogenicity studies on animals with vaccines comprised of H5N1 antigens and adjuvants manufactured under BARDA contracts. The results of this study will be used to support the filing of an investigational New Drug (IND) application by NIH and BARDA for clinical evaluation of these vaccine formulations as part of an interagency study to improve U.S. pandemic preparedness. The Government intends to conduct a commercial item acquisition available to all responsible quoters using Simplified Acquisition Procedures pursuant to FAR Parts 12 and 13, respectively. The issuance of a Request For Quotations on Fedbizopps.gov is anticipated on March 21, 2008; the anticipated solicitation response date will be fifteen days thereafter. The Government contemplates multiple awards of Indefinite Delivery / Indefinite Quantity contracts on or about April 21, 2008.

Similar Contracts

Same NAICS industry code

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 20 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS